Chemomab Therapeutics: Q1 Earnings Insights

Chemomab Therapeutics CMMB reported its Q1 earnings results on Thursday, May 12, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Earnings

Chemomab Therapeutics beat estimated earnings by 90.83%, reporting an EPS of $-0.022 versus an estimate of $-0.24.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.34 which was followed by a 7.92% increase in the share price the next day.

To track all earnings releases for Chemomab Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.